{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T11:18:09Z","timestamp":1701688689951},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13048-019-0515-3","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T17:02:34Z","timestamp":1560186154000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence of intraepithelial fallopian tube neoplasias in mexican women over 40 years of age that underwent elective hysterectomy"],"prefix":"10.1186","volume":"12","author":[{"given":"Antonio Gabriel","family":"Brise\u00f1o Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cruz Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Olivia","family":"Garc\u00eda Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Serna Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Gabriela","family":"Camarillo Elizalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Consuelo","family":"Robles Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/B978-0-443-07477-6.50028-7","volume-title":"Robboy's pathology of the female reproductive tract","author":"JV Lacey","year":"2009","unstructured":"Lacey JV, Sherman ME, Robboy SL, Mutter GL, Prat J, et al. Ovarian neoplasia. In: Robboy's pathology of the female reproductive tract. 2nd ed. Oxford: Churchill Livingstone Elsevier; 2009. p. 601.","edition":"2"},{"issue":"1","key":"515_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","volume":"29","author":"PT Kroeger Jr","year":"2017","unstructured":"Kroeger PT Jr, Dreapkin R. Pathogenesis and heterogeneity of ovarian cancer. Curr Opin Obstet Gynecol. 2017 Feb;29(1):26\u201334. \n                    https:\/\/doi.org\/10.1097\/GCO.0000000000000340\n                    \n                  .","journal-title":"Curr Opin Obstet Gynecol"},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fonc.2016.00108","volume":"6","author":"SH George","year":"2016","unstructured":"George SH, Garc\u00eda R, Slomovitz BM. Ovarian Cancer: the fallopian tube as the site of origin and opportunities for prevention. Front Oncol. 2016;6:108. \n                    https:\/\/doi.org\/10.3389\/fonc.2016.00108\n                    \n                   eCollection 2016.","journal-title":"Front Oncol"},{"key":"515_CR4","doi-asserted-by":"publisher","unstructured":"The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. J Obstet Gynaecol Can. 2014 Feb;36(2):133\u2013140. doi: \n                    https:\/\/doi.org\/10.1016\/S1701-2163(15\n                    \n                  ) 30659-9.","DOI":"10.1016\/S1701-2163(15"},{"key":"515_CR5","first-page":"45","volume":"76","author":"RP Zweemer","year":"2000","unstructured":"Zweemer RP, van Diest PJ, Verheijen RH, et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. GynecolOncol. 2000;76:45\u201350.","journal-title":"GynecolOncol"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/pin.12419","volume":"66","author":"N Nishida","year":"2016","unstructured":"Nishida N, Murakami F, Higaki K. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian c\u00e1ncer. Pathol Int. 2016;66:337\u201342.","journal-title":"Pathol Int"},{"key":"515_CR7","doi-asserted-by":"crossref","unstructured":"Singh, Naveena MD; Manchanda Ranjit, MD, Persistence of fimbrial tissue on the ovarian surface after salpingectomy. American Journal of Obstetrics & Gynecology 2017 425.e1-e16.","DOI":"10.1016\/j.ajog.2017.06.004"},{"key":"515_CR8","unstructured":"http:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html"},{"key":"515_CR9","first-page":"392","volume":"107","author":"SL Stewart","year":"2007","unstructured":"Stewart SL, Wike JM, Foster SL, Michaud F. The incidence of primary fallopian tube cancer in the United States. GynecolOncol. 2007;107:392.","journal-title":"GynecolOncol"},{"key":"515_CR10","unstructured":"\u00a9 2017 Programa de C\u00e1ncer de Ovario, INCAN."},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10937400701876095","volume":"11","author":"F Salehi","year":"2008","unstructured":"Salehi F, Dunfield L, Phillips KP, et al. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev. 2008;11:301.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/aje\/kwp371","volume":"171","author":"RBA MA","year":"2010","unstructured":"MA RBA, Hecht JL, Tworoger SS. Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol. 2010;171:45.","journal-title":"Am J Epidemiol"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/bjc.2011.371","volume":"105","author":"KK Tsilidis","year":"2011","unstructured":"Tsilidis KK, Allen NE, Key TJ, et al. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European prospective investigation into Cancer and nutrition. Br J Cancer. 2011;105:1436.","journal-title":"Br J Cancer"},{"key":"515_CR14","first-page":"641","volume":"108","author":"B Zhou","year":"2008","unstructured":"Zhou B, Sun Q, Cong R, et al. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. GynecolOncol. 2008;108:641.","journal-title":"GynecolOncol"},{"key":"515_CR15","first-page":"260","volume":"128","author":"LM Stewart","year":"2013","unstructured":"Stewart LM, Holman CD, Aboagye-Sarfo P, et al. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. GynecolOncol. 2013;128:260.","journal-title":"GynecolOncol"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","volume":"13","author":"CL Pearce","year":"2012","unstructured":"Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012;13:385.","journal-title":"Lancet Oncol"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","volume":"19","author":"BG Chittenden","year":"2009","unstructured":"Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod BioMed Online. 2009;19:398.","journal-title":"Reprod BioMed Online"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/aje\/kwm157","volume":"166","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Fairfield KM, Colditz GA, et al. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol. 2007;166:894.","journal-title":"Am J Epidemiol"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","volume":"33","author":"H Song","year":"2015","unstructured":"Song H, Dicks E, Ramus SJ, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian Cancer in the population. J ClinOncol. 2015;33:2901.","journal-title":"J ClinOncol"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11864-009-0108-2","volume":"10","author":"T Sueblinvong","year":"2009","unstructured":"Sueblinvong T, Carney ME. Current understanding of risk factors for ovarian cancer. CurrTreat Options Oncol. 2009;10:67.","journal-title":"CurrTreat Options Oncol"},{"key":"515_CR21","first-page":"292","volume":"124","author":"T Soini","year":"2014","unstructured":"Soini T, Hurskainen R, Gr\u00e9nman S, et al. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. ObstetGynecol. 2014;124:292.","journal-title":"ObstetGynecol"},{"key":"515_CR22","first-page":"42","volume":"12","author":"DC Whiteman","year":"2003","unstructured":"Whiteman DC, Siskind V, Purdie DM, Green AC. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomark Prev. 2003;12:42.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jnci\/92.14.1172","volume":"92","author":"DC Whiteman","year":"2000","unstructured":"Whiteman DC, Murphy MF, Cook LS, et al. Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst. 2000;92:1172.","journal-title":"J Natl Cancer Inst"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/j.1471-0528.2009.02322.x","volume":"116","author":"SK Myung","year":"2009","unstructured":"Myung SK, Ju W, Choi HJ, et al. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG. 2009;116:1697.","journal-title":"BJOG"},{"key":"515_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/155.3.217","volume":"155","author":"RB Ness","year":"2002","unstructured":"Ness RB, Cramer DW, Goodman MT, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2002;155:217.","journal-title":"Am J Epidemiol"},{"key":"515_CR26","first-page":"369","volume":"121","author":"L Yin","year":"2011","unstructured":"Yin L, Grandi N, Raum E, et al. Meta-analysis: circulating vitamin D and ovarian cancer risk. GynecolOncol. 2011;121:369.","journal-title":"GynecolOncol"},{"issue":"10","key":"515_CR27","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/cncr.30528","volume":"123","author":"Kara C. Long Roche","year":"2017","unstructured":"Kara C., Long Roche MD, Nadeem R Abu-Rustum MD, Mlica Nourmoussavi MD., Zivanovic, O. MD. Risk-reducing salpingectomy: Let us be opportunistic. Cancer. May 15. Volume 123, Issue 10 Pages: 1675\u20131876, 2017 \n                    https:\/\/doi.org\/10.1002\/cncr.30528\n                    \n                   Epub 2017 Mar 23.","journal-title":"Cancer"},{"key":"515_CR28","first-page":"192","volume":"102","author":"MS Rice","year":"2014","unstructured":"Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses. Health Studies FertilSteril. 2014;102:192.","journal-title":"Health Studies FertilSteril"},{"key":"515_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative ovarian Cancer group. Am J Epidemiol. 1992;136:1184.","journal-title":"Am J Epidemiol"},{"key":"515_CR30","first-page":"55","volume":"17","author":"D Cibula","year":"2011","unstructured":"Cibula D, Widschwendter M, M\u00e1jek O, Dusek L. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. HumReprodUpdate. 2011;17:55.","journal-title":"HumReprodUpdate"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0515-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:24:37Z","timestamp":1591658677000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0515-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0515-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The state research committee awarded the registration number (ISSEA-002\/18) to.the investigation. The patients signed informed consent for the surgical procedure.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from any individual person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"54"}}